Effects of Different Therapeutic Methods for Non-surgical Hepatocellular Carcinoma
Ping Sun
Abstract
Ping Sun
Abstract
To reveal the effects of different therapies for non-surgical hepatocellular carcinoma,the clinical datas of 144 patients were retrospectively analyzed.Survival rate of the patients in different group at 1,2,3 year was 86.4%,68.3%,58.2%;85.2%,59.0%,42.1%;100%,100%,42.9%;100%,94.7%,63.2%.Log-rank analysis suggested there were significantly difference in TACE and other treatment groups.Cox's proportional hazard regression model demonstrated that times of TACE,clinical stage and treatment methods were the independent risk factors affecting the survival(P0.05).Times of TACE、clinical stage and treatment methods can significantly affect the survival of non-surgical hepatocellular carcinoma patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To reveal the effects of different therapies for non-surgical hepatocellular carcinoma,the clinical datas of 144 patients were retrospectively analyzed.Survival rate of the patients in different group at 1,2,3 year was 86.4%,68.3%,58.2%;85.2%,59.0%,42.1%;100%,100%,42.9%;100%,94.7%,63.2%.Log-rank analysis suggested there were significantly difference in TACE and other treatment groups.Cox's proportional hazard regression model demonstrated that times of TACE,clinical stage and treatment methods were the independent risk factors affecting the survival(P0.05).Times of TACE、clinical stage and treatment methods can significantly affect the survival of non-surgical hepatocellular carcinoma patients.
Key concepts: Hepatocellular carcinoma, Medicine, Stage (stratigraphy), Proportional hazards model, Internal medicine, Gastroenterology, Hazard ratio, Oncology